ArticleRheumatology (Oxford, England)2022

Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS.

Hongjiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.